Blood folate level needed for fully effective neural tube defect prevention

Nicholas Wald,Stephen H Vale,Jonathan P Bestwick,Joan K Morris

DOI: https://doi.org/10.1101/2024.09.11.24313482

2024-09-19

Abstract:ABSTRACT Introduction Neural tube defects (NTDs) are a folate deficiency disorder. NTDs are preventable; increasing folic acid intake through food fortification or use of supplements increases serum and red blood cell folate and reduces the risk of a woman having an NTD pregnancy. There is controversy over whether there is a blood folate level needed to achieve the full preventive effect because of discrepant conclusions from studies investigating the relationship between folate levels and NTD risk. Resolving the controversy is important in determining public health policy. Methods Data from two studies conducted in Ireland and China were used to determine the relationship between serum folate and NTD risk. The relationship from each study was compared with the observed result in a randomised trial of folic acid that increased serum folate from 5 ng/ml to 44 ng/ml among the women who took the daily folic acid supplement before and during early pregnancy. Results Data from both studies showed a proportional (logarithmic) relationship between serum folate and NTD risk with no evidence of a folate threshold above which there is no further NTD risk reduction. Both studies accurately predicted the observed result from the randomised trial that achieved serum folate levels beyond the average levels found in the general population with an 83% preventive effect. This is higher than can be achieved with current levels of folic acid food fortification or with the recommended peri-conceptional use of 0.4mg supplements. The suggestion of a threshold is not due to discrepant data but the incorrect interpretation of the folate-NTD risk association when plotted on arithmetic scales which conceals the proportional relationship between the two. Conclusion To achieve fully effective fortification serum folate levels need to be about 44ng/ml.

Public and Global Health

What problem does this paper attempt to address?

The paper attempts to address the issue of whether there is a threshold for blood folate levels required to prevent neural tube defects (NTDs). Specifically, the paper aims to explore the following points:

1. **Controversial Background**: Existing studies have shown that increasing folate intake can significantly reduce the risk of NTDs, but there is controversy over the blood folate level required to achieve complete prevention. Some studies suggest that there is a threshold, beyond which further increases in folate levels do not provide additional risk reduction for NTDs; other studies suggest that no such threshold exists.

2. **Data Sources and Analysis**: The paper uses data from two studies conducted in Ireland and China, comparing the relationship between different folate levels and NTDs risk to verify the existence of a threshold. Additionally, it references the results of a randomized controlled trial, which showed that folate supplementation reduced NTDs risk by 83% when blood folate levels were increased from 5 ng/mL to 44 ng/mL.

3. **Conclusions**: The main conclusions of the paper are:
- There is a proportional (logarithmic) relationship between blood folate levels and NTDs risk, with no evidence of a threshold, meaning that increasing folate levels continuously reduces NTDs risk.
- Achieving fully effective folate fortification policies requires raising blood folate levels to approximately 44 ng/mL, which is higher than the current food fortification levels or the recommended periconceptional supplement dose (0.4 mg).
- This result can be used to guide public health activities, particularly in formulating more effective folate fortification policies to prevent the occurrence of NTDs.

In summary, the paper aims to clarify the controversy regarding the relationship between folate levels and NTDs risk and proposes reasonable public health activity goals.